Lung adenocarcinoma cell lines with EGFR mutations are also known to recruit regulatory T cells (Tregs) as a result of high C-C motif chemokine 22 (CCL22) expression, creating a suppressive tumor-immune microenvironment [75]. This evidence concerns the gene EGFR and lung adenocarcinoma.